Mesoblast Ownership | Who Owns Mesoblast?
Mesoblast Ownership Summary
Mesoblast is owned by 3.01% institutional investors, 5.09% insiders, and 91.90% retail investors. Legal & general group is the largest institutional shareholder, holding 0.53% of MESO shares. iShares Biotechnology ETF is the top mutual fund, with 0.39% of its assets in Mesoblast shares.
MESO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Mesoblast | 3.01% | 5.09% | 91.90% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Legal & general group | 679.02K | 0.53% | $12.24M |
| Blackrock funding, inc. /de | 676.37K | 0.53% | $12.20M |
| Morgan stanley | 596.95K | 0.47% | $10.77M |
| Goldman sachs group | 395.85K | 0.31% | $7.14M |
| Srs capital advisors | 200.12K | 0.17% | $3.23M |
| Jane street group | 167.38K | 0.13% | $3.02M |
| Royal bank of canada | 91.46K | 0.08% | $1.47M |
| Penbrook management | 87.58K | 0.07% | $1.58M |
| Ubs group | 72.56K | 0.06% | $1.31M |
| Prosperity wealth management | 49.95K | 0.04% | $804.70K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Penbrook management | 87.58K | 1.09% | $1.58M |
| Summit x | 199.29K | 0.40% | $2.17M |
| Lazari capital management | 46.12K | 0.28% | $832.02K |
| Prosperity wealth management | 49.95K | 0.27% | $804.70K |
| Fi3 financial advisors | 42.02K | 0.23% | $757.95K |
| Rialto wealth management | 46.50K | 0.20% | $838.86K |
| Bcs private wealth management | 16.00K | 0.10% | $288.64K |
| Caitong asset management | 1.90K | 0.09% | $34.28K |
| Srs capital advisors | 200.12K | 0.05% | $3.23M |
| Pine valley investments ltd liability | 20.93K | 0.02% | $414.43K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Srs capital advisors | 200.12K | 0.05% | 200.12K |
| Blackrock funding, inc. /de | 676.37K | 0.00% | 135.95K |
| Morgan stanley | 596.95K | 0.00% | 131.15K |
| Jane street group | 167.38K | 0.00% | 126.71K |
| Rialto wealth management | 46.50K | 0.20% | 46.50K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Oaktree capital management lp | - | - | -179.59K |
| Toronto dominion bank | - | - | -150.00K |
| Strategic financial concepts | - | - | -138.60K |
| Ubs group | 72.56K | 0.00% | -114.65K |
| Marex group | - | - | -100.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Srs capital advisors | 200.12K | 0.05% | 200.12K | $3.23M |
| Rialto wealth management | 46.50K | 0.20% | 46.50K | $838.86K |
| Polen capital management | 23.00K | 0.00% | 23.00K | $415.01K |
| Bcs private wealth management | 16.00K | 0.10% | 16.00K | $288.64K |
| Xtx topco | 15.75K | 0.01% | 15.75K | $253.75K |
Sold Out
| Holder | Change |
|---|---|
| Principal securities | -7.00 |
| Strengthening families & communities | -10.00 |
| Sjs investment consulting | -48.00 |
| Ronald blue trust | -91.00 |
| Bryn mawr trust | -686.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 67 | -11.84% | 3,831,999 | 4.17% | 3 | 32.44% | 30 | -18.92% | 15 | -11.76% |
| Sep 30, 2025 | 73 | 2.82% | 3,663,437 | 55.52% | 3 | 7119.91% | 34 | 3.03% | 17 | -5.56% |
| Jun 30, 2025 | 74 | 1.37% | 3,255,744 | -15.35% | - | 251.19% | 34 | -8.11% | 19 | 5.56% |
| Mar 31, 2025 | 73 | 7.35% | 3,846,194 | 21.24% | - | 326.03% | 38 | -19.15% | 17 | 112.50% |
| Dec 31, 2024 | 63 | 34.04% | 2,979,315 | 92.78% | - | 10.82% | 42 | 90.91% | 8 | -33.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Biotechnology ETF | 508.00K | 0.39% | 508.00K |
| iShares Nasdaq US Biotech ETF USD Acc | 35.30K | 0.03% | 35.30K |
| L&G Pharma Breakthrough ETF | 35.14K | 0.03% | - |
| Fidelity Nasdaq Composite Index | 30.74K | 0.02% | - |
| VT Downing Global Investors F Inc | 12.50K | 0.01% | - |
| Polen 5Perspectives Small Growth Instl | 10.53K | 0.01% | 10.53K |
| China Universal NASDAQ Bio-Tch ETF(QDII) | 9.12K | 0.01% | 2.35K |
| Polen Capital US Small Com Gr USD Instl | 5.69K | 0.00% | 5.69K |
| Quantified Global Fund Investor | 4.58K | 0.00% | 3.17K |
| ActivePassive International Equity ETF | 3.95K | 0.00% | 3.95K |
MESO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools